182 related articles for article (PubMed ID: 31130857)
1. Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells.
Huang C; Gan D; Luo F; Wan S; Chen J; Wang A; Li B; Zhu X
Front Pharmacol; 2019; 10():431. PubMed ID: 31130857
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways.
Wan S; Luo F; Huang C; Liu C; Luo Q; Zhu X
Aging (Albany NY); 2020 Jun; 12(11):10614-10632. PubMed ID: 32496208
[TBL] [Abstract][Full Text] [Related]
3. Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS.
Zhou M; Zhao X; Liao L; Deng Y; Liu M; Wang J; Xue X; Li Y
Oxid Med Cell Longev; 2022; 2022():9938392. PubMed ID: 35035671
[TBL] [Abstract][Full Text] [Related]
4. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
[TBL] [Abstract][Full Text] [Related]
5. The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.
Meng Y; Li T; Zhou GS; Chen Y; Yu CH; Pang MX; Li W; Li Y; Zhang WY; Li X
Antioxid Redox Signal; 2015 Jan; 22(3):241-58. PubMed ID: 25089563
[TBL] [Abstract][Full Text] [Related]
6. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
7. Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways.
Ren H; Li Y; Chen Y; Wang L
Drug Des Devel Ther; 2019; 13():285-290. PubMed ID: 30666090
[TBL] [Abstract][Full Text] [Related]
8. Scutellaria barbata D.Don extract regulates Ezrin-mediated triple negative breast cancer progress via suppressing the RhoA /ROCK1 signaling.
Niu J; Hu J; Wang Z
Toxicol Res (Camb); 2024 Apr; 13(2):tfae033. PubMed ID: 38525246
[TBL] [Abstract][Full Text] [Related]
9. Glaucocalyxin A Attenuates the Activation of Hepatic Stellate Cells Through the TGF-β1/Smad Signaling Pathway.
Dong Z; Gao Q; Guo H
DNA Cell Biol; 2018 Mar; 37(3):227-232. PubMed ID: 29327938
[TBL] [Abstract][Full Text] [Related]
10. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
11. Role of RhoA in platelet-derived growth factor-BB-induced migration of rat hepatic stellate cells.
Li L; Li J; Wang JY; Yang CQ; Jia ML; Jiang W
Chin Med J (Engl); 2010 Sep; 123(18):2502-9. PubMed ID: 21034618
[TBL] [Abstract][Full Text] [Related]
12. Effect of RhoA on transforming growth factor β1-induced rat hepatic stellate cell migration.
Li L; Wang JY; Yang CQ; Jiang W
Liver Int; 2012 Aug; 32(7):1093-102. PubMed ID: 22498718
[TBL] [Abstract][Full Text] [Related]
13. IRE1α/NOX4 signaling pathway mediates ROS-dependent activation of hepatic stellate cells in NaAsO
Tao Y; Qiu T; Yao X; Jiang L; Wang N; Jiang J; Jia X; Wei S; Zhang J; Zhu Y; Tian W; Yang G; Liu X; Liu S; Ding Y; Sun X
J Cell Physiol; 2021 Feb; 236(2):1469-1480. PubMed ID: 32776539
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
15. Oxycodone inhibits myocardial cell apoptosis after myocardial ischemia-reperfusion injury in rats via RhoA/ROCK1 signaling pathway.
Xie Y; Ge CL; Zhang ZY; Fei GX
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6371-6379. PubMed ID: 32572934
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid suppresses TGF-β1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling.
Yu SS; Chen B; Huang CK; Zhou JJ; Huang X; Wang AJ; Li BM; He WH; Zhu X
Exp Ther Med; 2017 Oct; 14(4):3577-3582. PubMed ID: 29042951
[TBL] [Abstract][Full Text] [Related]
17. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells.
Wang X; Ikejima K; Kon K; Arai K; Aoyama T; Okumura K; Abe W; Sato N; Watanabe S
J Hepatol; 2011 Aug; 55(2):379-87. PubMed ID: 21168456
[TBL] [Abstract][Full Text] [Related]
19. Schisandrin B inhibits tumor progression of hepatocellular carcinoma by targeting the RhoA/ROCK1 pathway.
Yang H; Wu T
J Gastrointest Oncol; 2023 Apr; 14(2):533-543. PubMed ID: 37201042
[TBL] [Abstract][Full Text] [Related]
20. Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis.
Wang Y; Li Y; Qiu Y; Shen M; Wang L; Shao J; Zhang F; Xu X; Zhang Z; Guo M; Zheng S
J Clin Transl Hepatol; 2024 Jan; 12(1):36-51. PubMed ID: 38250467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]